Showing results (51-60 of 468) with videos related to
Sort By:
Pageof 47
Expert Review of Gastroenterology & Hepatology|September 15, 2015
Is obesity an advantage in patients with colorectal cancer?Pashtoon Murtaza Kasi, S Yousuf Zafar, Axel GrotheyCancer Journal (Sudbury, Mass.)|April 21, 2010
The role of chemotherapy in managing patients with resectable liver metastasesThorvardur R Halfdanarson, Michael L Kendrick, Axel GrotheyClinical Advances in Hematology & Oncology : H&O|March 24, 2016
Current Options for Third-Line Treatment of Metastatic Colorectal CancerAxel Grothey, John L Marshall, Tara E SeeryEuropean Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 3, 2004
Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda)Hilde Marsé, Eric Van Cutsem, Axel Grothey, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 17, 2005
Costs of treatment of colorectal cancer in different settings in GermanyKlaus Hieke, Ulrich R Kleeberg, Martina Stauch, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2005
Granisetron versus tropisetron for prophylaxis of acute chemotherapy-induced emesis: a pooled analysisKarin Jordan, Axel Hinke, Axel Grothey, et al.Onkologie|January 22, 2005
Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomitingKarin Jordan, Axel Grothey, Thomas Kegel, et al.JCO Oncology Practice|April 21, 2021
Evolution and Current Status of the Multidisciplinary Management of Locally Advanced Rectal CancerBenjamin W Deschner, Noam A VanderWalde, Axel Grothey, et al.European Journal of Cancer (Oxford, England : 1990)|June 24, 2008
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategiesSherry Wolf, Debra Barton, Lisa Kottschade, et al.Journal of the National Cancer Institute|August 2, 2015
The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical TrialsGita Thanarajasingam, Joleen M Hubbard, Jeff A Sloan, et al.Pageof 47